VTGN icon

VistaGen Therapeutics
VTGN

Overview Fund Activity

21 hedge funds and large institutions have $2.36M invested in VistaGen Therapeutics in 2019 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 7 closing their positions.

Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.46%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
3
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HighTower Advisors
1
HighTower Advisors
Illinois
$96K
2
Wells Fargo
2
Wells Fargo
California
$31K
3
LPL Financial
3
LPL Financial
California
$27K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$868K
5
UBS Group
5
UBS Group
Switzerland
$11K

Top Sellers

1
Point72 Asset Management
1
Point72 Asset Management
Connecticut
$0
2
SFM
2
Sphera Funds Management
Israel
$489K
3
ECM
3
Endurant Capital Management
California
$0
4
WVP
4
Worth Venture Partners
New Jersey
$0
5
AAP
5
Ardsley Advisory Partners
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Jane Street
26
Jane Street
New York
– – -22,341 Closed
Koshinski Asset Management
27
Koshinski Asset Management
Illinois
– – -20,000 Closed
HP
28
Hikari Power
Japan
– – -10,635 Closed
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
1
2